Kuopio, Finland

Mauno M Airaksinen

This inventor holds 1 USPTO granted patent. Top assignee: Orion-Yhtyma Oy. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mauno M Airaksinen. Retrieved from https://idiyas.com/inventor/mauno-m-airaksinen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mauno M Airaksinen: Innovator in Cognitive Disorder Treatments

Introduction

Mauno M Airaksinen is a notable inventor based in Kuopio, Finland. He has made significant contributions to the field of cognitive health, particularly in the treatment of age-related cognitive disorders. His work has garnered attention for its potential impact on improving the quality of life for individuals facing cognitive decline.

Latest Patents

Airaksinen holds a patent for "Imidazoles for the treatment of age-related cognitive disorders." This innovative approach aims to address the challenges associated with cognitive decline in aging populations. His patent reflects a commitment to advancing medical science and improving therapeutic options for patients.

Career Highlights

Throughout his career, Airaksinen has been associated with Orion-Yhtyma Oy, a prominent company in the pharmaceutical industry. His role at the company has allowed him to collaborate with other experts in the field, further enhancing his contributions to cognitive health research.

Collaborations

Airaksinen has worked alongside esteemed colleagues, including Paavo J Riekkinen and Paavo J Riekkinen, Jr. These collaborations have enriched his research and development efforts, leading to innovative solutions in the treatment of cognitive disorders.

Conclusion

Mauno M Airaksinen's work exemplifies the spirit of innovation in the medical field. His dedication to developing treatments for age-related cognitive disorders highlights the importance of research and collaboration in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…